BJP College Seminars Series
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brockington, I. F.
Right arrow Articles by Wainwright, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brockington, I. F.
Right arrow Articles by Wainwright, S.

The British Journal of Psychiatry 133: 162-168 (1978)
© 1978 The Royal College of Psychiatrists

Trials of lithium, chlorpromazine and amitriptyline in schizoaffective patients

IF Brockington, RE Kendell, JM Kellett, SH Curry and S Wainwright

Two drug trials in schizoaffective patients are reported. Nineteen "schizomanic" patients were treated for one month, on a double blind basis, with chlorpromazine or lithium and 41 "schizodepressive" patients with amitriptyline, chlorpromazine or both. In the schizodepressive patients there was a trend to a better response to chlorpromazine, but drug response generally was poor, only 20 per cent of patients recovering within the month. In the schizomanic patients lithium seemed as effective as chlorpromazine, which supports the view that these patients were suffering from a variant of mania.


This article has been cited by other articles:


Home page
 Schizophr BullHome page
R. Dutta, T. Greene, J. Addington, K. McKenzie, M. Phillips, and R. M. Murray
Biological, Life Course, and Cross-Cultural Studies All point Toward the Value of Dimensional and Developmental Ratings in the Classification of Psychosis
Schizophr Bull, July 1, 2007; 33(4): 868 - 876.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
D. F. Levinson, C. Umapathy, and M. Musthaq
Treatment of Schizoaffective Disorder and Schizophrenia With Mood Symptoms
Am J Psychiatry, August 1, 1999; 156(8): 1138 - 1148.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1978 The Royal College of Psychiatrists.